Back to funds
View filing
Prosight Management, LP
hedge fundUpdated 29 days agoManaged by Prosight Management, Lp • Latest filing Q2 2026
Portfolio value
$580.4M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $210.9M |
| Q2 2023 | $325.8M |
| Q3 2023 | $315.5M |
| Q4 2023 | $249.1M |
| Q1 2024 | $359.5M |
| Q2 2024 | $334.6M |
| Q3 2024 | $406.4M |
| Q4 2024 | $361.8M |
| Q1 2025 | $304.3M |
| Q2 2025 | $410.1M |
| Q3 2025 | $428.8M |
| Q4 2025 | $483.9M |
| Q1 2026 | $609.8M |
| Q2 2026 | $580.4M |
Top holdings
36 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | G GLPGF LAKEFRONT BIOTHERAPEUTICS NV | $61.3M | 2.04M | 10.56% | — |
| 2 | J JANX JANUX THERAPEUTICS INC | $58.4M | 3.80M | 10.07% | — |
| 3 | N NKTR NEKTAR THERAPEUTICS | $56.5M | 810.0K | 9.74% | — |
| 4 | B BSX BOSTON SCIENTIFIC CORP | $54.2M | 1.27M | 9.34% | — |
| 5 | S STTK SHATTUCK LABS INC | $41.3M | 5.96M | 7.12% | — |
| 6 | I INSM INSMED INC | $40M | 375.6K | 6.90% | — |
| 7 | A ALNY ALNYLAM PHARMACEUTICALS INC | $29.5M | 98.1K | 5.09% | — |
| 8 | S SNDX SYNDAX PHARMACEUTICALS INC | $26.2M | 1.20M | 4.52% | — |
| 9 | K KURA KURA ONCOLOGY INC | $22.2M | 2.02M | 3.82% | — |
| 10 | A ALKS ALKERMES PLC | $20.7M | 394.4K | 3.56% | — |
| 11 | I IRTC IRHYTHM HOLDINGS INC | $19.7M | 165.5K | 3.39% | — |
| 12 | V VEEV VEEVA SYS INC | $18.8M | 106.2K | 3.25% | — |
| 13 | Z ZYME ZYMEWORKS INC | $17.6M | 674.4K | 3.04% | — |
| 14 | A AAVXF ABIVAX SA | $14.3M | 107.4K | 2.47% | — |
| 15 | C CRNX CRINETICS PHARMACEUTICALS IN | $14M | 374.7K | 2.42% | — |
| 16 | M MLYS MINERALYS THERAPEUTICS INC | $12.1M | 449.8K | 2.09% | — |
| 17 | A ADCT ADC THERAPEUTICS SA | $8.4M | 7.82M | 1.44% | — |
| 18 | I ICUI ICU MED INC | $7.5M | 51.0K | 1.29% | — |
| 19 | I ISRG INTUITIVE SURGICAL INC | $6.8M | 17.0K | 1.16% | — |
| 20 | C CRBP CORBUS PHARMACEUTICALS HLDGS | $6.1M | 650.0K | 1.05% | — |